Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Combined Computational And Experimental Studies Of Molecular Interactions Of Albuterol Sulfate With Bovine Serum Albumin For Pulmonary Drug Nanoparticles

Shaohui Lin, W. Cui, G. Wang, S. Meng, Y. Liu, Hong-wei Jin, Liang-ren Zhang, Y. Xie
Published 2016 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Albumin-based nanoparticles (NPs) are a promising technology for developing drug-carrier systems, with improved deposition and retention profiles in lungs. Improved understanding of these drug–carrier interactions could lead to better drug-delivery systems. The present study combines computational and experimental methods to gain insights into the mechanism of binding of albuterol sulfate (AS) to bovine serum albumin (BSA) on the molecular level. Molecular dynamics simulation and surface plasmon resonance spectroscopy were used to determine that there are two binding sites on BSA for AS: the first of which is a high-affinity site corresponding to AS1 and the second of which appears to represent the integrated functions of several low-affinity sites corresponding to AS2, AS3, and AS8. AS1 was the strongest binding site, established via electrostatic interaction with Glu243 and Asp255 residues in a hydrophobic pocket. Hydrogen bonds and salt bridges played a main role in the critical binding of AS1 to BSA, and water bridges served a supporting role. Based upon the interaction mechanism, BSA NPs loaded with AS were prepared, and their drug-loading efficiency, morphology, and -release profiles were evaluated. Successful clinical development of AS-BSA-NPs may improve therapy and prevention of bronchospasm in patients with reversible obstructive airway disease, and thus provide a solid basis for expanding the role of NPs in the design of new drug-delivery systems.
This paper references
Ganciclovir-loaded albumin nanoparticles: characterization and in vitro release properties.
M. Merodio (2001)
A unified formulation of the constant temperature molecular dynamics methods
Shūichi Nosé (1984)
Fluorescence spectral studies on interaction of fluorescent probes with Bovine Serum Albumin (BSA)
K. Ghosh (2016)
Atomic structure and chemistry of human serum albumin
X. M. He (1993)
A point‐charge force field for molecular mechanics simulations of proteins based on condensed‐phase quantum mechanical calculations
Y. Duan (2003)
LINCS: A linear constraint solver for molecular simulations
B. Hess (1997)
Kinetic Analyses of Data from a Human Serum Albumin Assay Using the liSPR System
A. Henseleit (2015)
Protein transport across the lung epithelial barrier.
K. Kim (2003)
Development of a Surface Plasmon Resonance Assay for the Characterization of Small-Molecule Binding Kinetics and Mechanism of Binding to Kynurenine 3-Monooxygenase.
Suresh B Poda (2015)
Binding of antiinflammatory drug cromolyn sodium to bovine serum albumin
Yj Hu (2006)
Discovery of potential drugs for human-infecting H7N9 virus containing R294K mutation
Jiao-Yu He (2014)
Modeling the interaction of interferon α-1b to bovine serum albumin as a drug delivery system.
Q. Luo (2014)
Binding of anti-inflammatory drug cromolyn sodium to bovine serum albumin.
Y. Hu (2006)
Protein/ligand binding free energies calculated with quantum mechanics/molecular mechanics.
F. Gräter (2005)
Bovine serum albumin nanoparticles as controlled release carrier for local drug delivery to the inner ear
Z. Yu (2014)
Preparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for liver target
M Merodio (2008)
Structural and immunologic characterization of bovine, horse, and rabbit serum albumins.
K. Majorek (2012)
Large porous particles for pulmonary drug delivery.
D. Edwards (1997)
Albuterol via metered‐dose inhaler in children: Lower doses are effective, and higher doses are safe
F. P. Muchão (2016)
Albumin-based nanoparticles as potential controlled release drug delivery systems.
Ahmed O Elzoghby (2012)
The Amber biomolecular simulation programs
D. A. Case (2005)
Therapeutic advantage of inhaled tacrolimus-bound albumin nanoparticles in a bleomycin-induced pulmonary fibrosis mouse model.
J. Seo (2016)
Pulmonary Delivery of Voriconazole Loaded Nanoparticles Providing a Prolonged Drug Level in Lungs: A Promise for Treating Fungal Infection.
P. J. Das (2015)
Large Porous Hollow Particles: Lightweight Champions of Pulmonary Drug Delivery.
S. Gharse (2016)
In vivo biocompatibility, clearance, and biodistribution of albumin vehicles for pulmonary drug delivery
A. Woods (2015)
Mechanism of drug release from polymethacrylate-based extrudates and milled strands prepared by hot-melt extrusion.
J. Albers (2009)
albuterol sulfate–Bsa nPs for pulmonary disease
g_mmpbsa - A GROMACS Tool for High-Throughput MM-PBSA Calculations
R. Kumari (2014)
Preparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for liver targeting.
F. Li (2008)
Safety and Efficacy of nab-Paclitaxel in the Treatment of Patients with Breast Cancer
P. Vishnu (2011)
Safety and efficacy of nabpaclitaxel in the treatment of patients with breast cancer
P Vishnu (2011)
EGCG reverses human neutrophil elastase-induced migration in A549 cells by directly binding to HNE and by regulating α1-AT
Yilixiati Xiaokaiti (2015)
Rational design of liposomal drug delivery systems, a review: Combined experimental and computational studies of lipid membranes, liposomes and their PEGylation.
A. Bunker (2016)
Trojan Microparticles for Drug Delivery
N. Anton (2012)
Investigation of the Interaction of Naringin Palmitate with Bovine Serum Albumin: Spectroscopic Analysis and Molecular Docking
X. Zhang (2013)
GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers
M. Abraham (2015)
Inhalable self-assembled albumin nanoparticles for treating drug-resistant lung cancer.
S. H. Choi (2015)
Determination of albuterol sulfate and its related substances in albuterol sulfate inhalation solution, 0.5% by RP-HPLC.
Satyajit V Erram (2006)
Nanoparticles for drug delivery to the lungs.
Jean Sung (2007)
Nanoparticle agglomerates of fluticasone propionate in combination with albuterol sulfate as dry powder aerosols.
N. El-gendy (2011)
Bovine serum albumin nanoparticles for delivery of tacrolimus to reduce its kidney uptake and functional nephrotoxicity.
L. Zhao (2015)
Fluorescence spectroscopy and molecular simulation on the interaction of caffeic acid with human serum albumin.
Yuhong Xiang (2016)
Advanced Glycation End Products Modulate Structure and Drug Binding Properties of Albumin.
Saurabh Awasthi (2015)
Free Energy Calculations by the Molecular Mechanics Poisson−Boltzmann Surface Area Method
Nadine Homeyer (2012)
In silico prediction of human serum albumin binding for drug leads
Theodosia Vallianatou (2013)
Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems
T. Darden (1993)
Albumin nanoparticles increase the anticancer efficacy of albendazole in ovarian cancer xenograft model
Lubna Noorani (2015)
Evolution of dry powder inhaler design, formulation, and performance.
S. Newman (2002)
Elucidating the Influence of Gold Nanoparticles on the Binding of Salvianolic Acid B and Rosmarinic Acid to Bovine Serum Albumin
Xin Peng (2015)
Local water bridges and protein conformational stability
M. Petukhov (1999)
Interactive Association of Drugs Binding to Human Serum Albumin
Feng Yang (2014)
BSA Nanoparticle Loaded Atorvastatin Calcium - A New Facet for an Old Drug
Sripriyalakshmi. S (2014)
Gaussian 03 [software]. Wallingford (CT): Gaussian Inc
Mj Frisch (2004)
Hydrogen bonds and salt bridges across protein-protein interfaces.
D. Xu (1997)
Comparison of simple potential functions for simulating liquid water
W. Jorgensen (1983)
Multiple binding modes of a small molecule to human Keap1 revealed by X-ray crystallography and molecular dynamics simulation
Mikiya Satoh (2015)
Evaluation of alternatives to warfarin as probes for Sudlow site I of human serum albumin: characterization by high-performance affinity chromatography.
K. S. Joseph (2009)
Characterisation of the de-agglomeration effects of bovine serum albumin on nanoparticles in aqueous suspension.
R. Tantra (2010)
Computational studies of transport in ion channels using metadynamics.
S. Furini (2016)
Drug Design, Development and Therapy
Z. Cai (2012)
Preparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for liver target
FQ Li (2008)
Arsenic trioxide binding to serum proteins.
Sara Shooshtary (2015)
Locating high-affinity fatty acid-binding sites on albumin by x-ray crystallography and NMR spectroscopy.
J. R. Simard (2005)
Electrostatics of nanosystems: Application to microtubules and the ribosome
Nathan A. Baker (2001)
Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses
A. Singh (2015)
ACPYPE - AnteChamber PYthon Parser interfacE
A. W. Sousa da Silva (2012)
DoGSiteScorer: a web server for automatic binding site prediction, analysis and druggability assessment
A. Volkamer (2012)
Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis.
J. R. Simard (2006)
Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles.
F. Kratz (2008)
Five recombinant fragments of human serum albumin—tools for the characterization of the warfarin binding site
M. Dockal (2000)
Surface Plasmon Resonance: A Versatile Technique for Biosensor Applications
H. H. Nguyen (2015)
Development and testing of a general amber force field
J. Wang (2004)
Polymorphic transitions in single crystals: A new molecular dynamics method
M. Parrinello (1981)
Evaluation of indole-based probes for high-throughput screening of drug binding to human serum albumin: Analysis by high-performance affinity chromatography.
Mandi L Conrad (2009)

This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar